Australia's most trusted
source of pharma news
Posted 9 July 2024 PM
A recent survey has revealed the general public isn't sufficiently aware of individual pharmaceutical companies to have an opinion on them.
Reputation management company Caliber surveyed over 30,000 people across 13 countries to gauge public perception of pharma companies. Respondents were asked to rate 34 pharmas, selected on having a global market cap of at least $37 billion (US$25 billion) at the end of 2023, to form the basis of the Pharmaceuticals Global Reputation Report 2024.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.